Greene Barry E - Aug 11, 2022 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith, Attorney-in-Fact for Barry Greene
Stock symbol
KPTI
Transactions as of
Aug 11, 2022
Transactions value $
$11,250
Form type
4
Date filed
8/15/2022, 08:05 AM
Previous filing
May 20, 2022
Next filing
Nov 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Options Exercise $11.3K +7.58K +125.64% $1.49 13.6K Aug 11, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Stock Option (right to buy) Options Exercise $0 -7.58K -100% $0.00* 0 Aug 11, 2022 Common Stock 7.58K $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option, representing a right to purchase a specified number of shares, vested as to 25% of the shares on January 14, 2014, and the remaining 75% vested in 36 equal monthly installments thereafter.